Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
A. Addetia, C. Stewart, A. J. Seo, K. R. Sprouse, A. Y. Asiri, M. Al-Mozaini, Z. A. Memish, A. Alshukairi, D. Veesler
This study maps immunodominant sites on MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans, showing peak neutralizing activity against S1 and RBD epitopes.
bioRxiv · Mar 31, 2024Immunology